Overview

A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain

Status:
Completed
Trial end date:
2020-06-11
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.
Phase:
Phase 3
Details
Lead Sponsor:
Centrexion Therapeutics
Treatments:
Capsaicin